ACTIVITY NUMBER: MHPTM002
ACTIVITY TITLE: Mental Health Professional Training Modules Part 2: Treatment Interventions
CREDIT DESIGNATION STATEMENT
The American Society for Reproductive Medicine designates this enduring material for a maximum of 7.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Mental Health Professionals Group of the American Society for Reproductive Medicine is approved by the American Psychological Association to sponsor continuing education for psychologists. This activity will offer 7.00 continuing education credits. The Mental Health Professionals Group of the American Society for Reproductive Medicine maintains responsibility for this program and its content.
Release Date: June 1, 2017
Reviewed/Updated: January 5, 2023
Expiration Date: January 5, 2026
Estimated Time to Complete Activity: 7.00 hours
NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP
Mental Health Professionals experience significant challenges when working in reproductive medicine. The competence required to practice in this area does not carry over from other mental health care settings. Treatment interventions that take into consideration the scientific, medical, and psychological aspects of infertility treatments must be designed and/or adapted specifically for infertility patients. As new treatments evolve, complex ethical and legal/regulatory issues arise. Psychological research must be rigorous and suitably designed to address the unique questions in this field. Part 2 of the Mental Health Professional Training Modules provides an opportunity for mental health practitioners to be introduced to and understand treatment interventions, ethics, fertility preservation and research in assisted reproductive technology. Successful completion of Part 1, Mental Health Professional Training Modules: Basic Infertility is a prerequisite to this course.
Completion of the MHPG Training Modules or any of their components does not provide credentials to practice as a mental health professional in the assisted reproductive technology setting.
At the conclusion of the educational activity, participants should be able to:
1. Analyze and apply ethical principles in treating patients using assisted reproductive technologies (ART).
2. Identify treatment interventions that are relevant for patients in ART.
3. Apply the basic principles of research applicable to ART psychological paradigms.
Lesson 1 Ethical Practices in Fertility Counseling
1A Ethical Principles
1B Ethical Dilemmas
1C Implicit Bias
Lesson 2 Cognitive and Dialectical Behavior Informed Therapy for Infertility
Lesson 3 Couples Counseling in Infertility: Emotionally Focused Therapy (EFT)
Lesson 4 The Intersection of Sexual Function and Infertility
Lesson 5 Infertility and Grief Counseling
Lesson 6 Stress Management and Coping: Approaches to Working with the Infertility Patient
Lesson 7 Psychotropic Medications for Depression and Anxiety during Assisted Reproductive Technology (ART) and Pregnancy
Lesson 8 Clinical Research: Fertility and Reproductive Medicine
Lesson 9 The Role of Mental Health Professionals in Adult Fertility Preservation
This activity has been designed to meet the educational needs of mental health professionals involved in infertility care.
Interpersonal and Communication Skills
SUCCESSFUL COMPLETION REQUIREMENTS
Successful completion of this activity requires the learner to:
· Successfully complete MHPCC001/MHPTM Part 1: Basic Infertility as a prerequisite for this training module
· View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of each module.
· Complete a 45-question pre-exam prior to the training module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.
· Be given the option of downloading printed presentation and supporting materials.
· Participate in the interactive activities: audio narration is synchronized with presentation materials that can be advanced, stopped, or reversed as desired.
· After completion of all 9 lessons, take a 45-question post-exam, with feedback of correct/incorrect answers, scoring a minimum of 75% in two attempts.
· Complete the evaluation survey.
· Print certificate of completion.
DISCLOSURES FOR PLANNERS AND FACULTY
Michelle Landrum, EdD(c) – Nothing to Disclose
Harriet Smith, M.Ed – Nothing to Disclose
Shelley Lee, PhD – Nothing to Disclose
Irena Milentijevic, PsyD – Nothing to Disclose
Melanie Mikkelsen - Nothing to Disclose
Ariadna Cymet-Lanski - Nothing to Disclose
Susan A. Gitlin, PhD – Nothing to Disclose
Content Developers and Reviewers
Kim Bergman, PhD – Nothing to Disclose
Angela Lawson, PhD – Nothing to Disclose
Danielle Kaplan, PhD – Nothing to Disclose
Irena Milentijevic, PsyD – Nothing to Disclose
Bill Petok, PhD – Nothing to Disclose
Melanie Mikkelsen, MSW, LICSW – Nothing to Disclose
Piave Lake, MD - Nothing to Disclose
Jessica Clifton, PhD - Nothing to Disclose
Jean Benward, MSW – Nothing to Disclose
Kris Bevilacqua, PhD – Nothing to Disclose
Julie Bindeman, PhD - Nothing to Disclose
Andrea Braverman, PhD – Nothing to Disclose
Shara Brofman, PhD – CVS Stock Ownership
Nicole Cirino, MD – Nothing to Disclose
Bonnie Cochran, LCSW – Nothing to Disclose
Alice Domar, PhD – Consultant: Merck, Ferring, Ovascience; Ownership/Stock: TriaDea Integrative Health Center and FertiCalm
Amanda Ellis, RN, BSN – Nothing to Disclose
Allison Fagan, PhD – Spouse on Speaker’s Bureau – AstraZeneca, Allergan, Mylan
Nancy Freeman-Carroll, PsyD – Nothing to Disclose
Joann Galst, PhD - Nothing to Disclose
Elizabeth Grill, PsyD – Co-Owner: Ferticalm, AlizHealthcare
Judith Horowitz, PhD – Nothing to Disclose
Daniel Kaser, MD - Nothing to Disclose
Sheryl Kingsberg, PhD – Paid Consultant: Valeant, Acerus, Emotional Brain, Pfizer, Shionogi, Sermonix, NovoNordisk, Perrigo, Nuelle, Materna, Palatin; Stock Options: Viveve
Sue Clock, PhD – ForsMarsh, LLC
Lauri Pasch, PhD – Nothing to Disclose
Debra Reuben, PhD – Nothing to Disclose
Mindy Shiffman, PhD – Nothing to Disclose
Carly Snyder, MD – Speaker: Sage Therapeutics
Irene Souter, MD – Nothing to Disclose
Margot Weinshel, LCSW, RN – Nothing to Disclose
Julianne E. Zweifel, PhD – Nothing to Disclose
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity are expected to disclose any relationships they may have with companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.
This CME activity is sponsored by the American Society for Reproductive Medicine
STATEMENT of SUPPORT
No commercial support was provided for this activity.